First Trust Nasdaq Pharmaceuticals Etf ETF Forecast

Buy or Hold candidate since May 21, 2026 Gain 5.16%

The FIRST TRUST NASDAQ PHARMACEUTICALS ETF price gained 1.37% on the last trading day (Tuesday, 23rd Jun 2026), rising from $35.83 to $36.32. During the last trading day the ETF fluctuated 1.24% from a day low at $35.94 to a day high of $36.38. The price has fallen in 6 of the last 10 days but is still up by 3.41% over the past 2 weeks. Volume fell on the last day by -3 thousand shares and in total, 6 thousand shares were bought and sold for approximately $226.57 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The ETF has broken the weak rising the short-term trend up and an even stronger rate of rising is indicated. For any reaction back there will now be support on the roof on the current trend broken at $36.24, a level that may pose a second chance to hit a runner. According to fan-theory $38.09 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.

FTXH Signals & Forecast

The FIRST TRUST NASDAQ PHARMACEUTICALS ETF holds buy signals from both short and long-term Moving Averages giving a positive forecast for the ETF. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $35.81 and $34.83. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, June 02, 2026, and so far it has risen 6.95%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not. The ETF had a Golden Star Signal on Wednesday, May 20, 2026 in the short-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the ETF in question.

Support, Risk & Stop-loss for FIRST TRUST NASDAQ PHARMACEUTICALS ETF

FIRST TRUST NASDAQ PHARMACEUTICALS finds support from accumulated volume at $35.64 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the ETF tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the ETF During the last day, the ETF moved $0.445 between high and low, or 1.24%. For the last week the ETF has had daily average volatility of 1.31%

Our recommended stop-loss: $34.79 (-4.21%) (This ETF has very low daily movements and this gives very low risk. There is a buy signal from a pivot bottom found 14 days ago.)

Trading Expectations (FTXH) For The Upcoming Trading Day Of Wednesday 24th

For the upcoming trading day on Wednesday, 24th we expect FIRST TRUST NASDAQ PHARMACEUTICALS ETF to open at $36.21, and during the day (based on 14 day Average True Range), to move between $36.06 and $36.57, which gives a possible trading interval of +/-$0.516 (+/-1.43%) up or down from last closing price. If FIRST TRUST NASDAQ PHARMACEUTICALS ETF takes out the full calculated possible swing range there will be an estimated 1.43% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $35.64, some $0.677 (1.87%) from the current price of $36.32, our system finds the risk reward attractive.

Is FIRST TRUST NASDAQ PHARMACEUTICALS ETF ETF A Buy?

FIRST TRUST NASDAQ PHARMACEUTICALS holds several positive signals and has broken the weak rising trend up. As the ETF is also in great technical shape we, therefore, consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our analysis conclusion for this ETF since the last evaluation from a Buy to a Strong Buy candidate.

Current score: 6.722 Strong Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 24, 2026 - $36.21 ( 0.291%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk